These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 9614013)

  • 41. Implementation of near-universal hydroxyurea uptake among children with sickle cell anemia: A single-center experience.
    Karkoska K; Todd K; Niss O; Clapp K; Fenchel L; Kalfa TA; Malik P; Quinn CT; Ware RE; McGann PT
    Pediatr Blood Cancer; 2021 Jun; 68(6):e29008. PubMed ID: 33742510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hydroxyurea for ALL children with sickle cell anemia: What can we learn from Africa?
    Aygun B
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28164. PubMed ID: 31925887
    [No Abstract]   [Full Text] [Related]  

  • 43. Hydroxyurea and new agents for the treatment of sickle cell disease.
    Rodgers GP
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):713-5. PubMed ID: 16163257
    [No Abstract]   [Full Text] [Related]  

  • 44. Long-term use of hydroxyurea for sickle cell anemia.
    Feldman L; Allen S; Westerman M; Feldman L; Gilman-Sachs A; Beaman K
    JAMA; 2003 Aug; 290(6):752-3; author reply 754. PubMed ID: 12915423
    [No Abstract]   [Full Text] [Related]  

  • 45. Long-term use of hydroxyurea for sickle cell anemia.
    Spell DW
    JAMA; 2003 Aug; 290(6):752; author reply 754. PubMed ID: 12915422
    [No Abstract]   [Full Text] [Related]  

  • 46. Hydroxyurea for children with sickle cell disease.
    Heeney MM; Ware RE
    Pediatr Clin North Am; 2008 Apr; 55(2):483-501, x. PubMed ID: 18381097
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent.
    Rigano P; De Franceschi L; Sainati L; Piga A; Piel FB; Cappellini MD; Fidone C; Masera N; Palazzi G; Gianesin B; Forni GL;
    Blood Cells Mol Dis; 2018 Mar; 69():82-89. PubMed ID: 29107441
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hydroxyurea for children with sickle cell disease: are we starting too late?
    Mueller BU
    Pediatr Blood Cancer; 2011 Jan; 56(1):3-4. PubMed ID: 21058289
    [No Abstract]   [Full Text] [Related]  

  • 49. Long-term use of hydroxyurea for sickle cell anemia.
    Hagar W
    JAMA; 2003 Aug; 290(6):753; author reply 754. PubMed ID: 12915424
    [No Abstract]   [Full Text] [Related]  

  • 50. NIH consensus development statement on hydroxyurea treatment for sickle cell disease.
    Brawley OW; Cornelius LJ; Edwards LR; Gamble VN; Green BL; Inturrisi CE; James AH; Laraque D; Mendez MH; Montoya CJ; Pollock BH; Robinson L; Scholnik AP; Schori M
    NIH Consens State Sci Statements; 2008 Feb 27-29; 25(1):1-30. PubMed ID: 18309362
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hydroxyurea Initiation Among Children With Sickle Cell Anemia.
    Reeves SL; Jary HK; Gondhi JP; Raphael JL; Lisabeth LD; Dombkowski KJ
    Clin Pediatr (Phila); 2019 Nov; 58(13):1394-1400. PubMed ID: 31113236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. European register of patients with sickle cell disease treated with hydroxyurea is being set up.
    Davies SC; Roberts-Harwood M
    BMJ; 1998 Aug; 317(7157):541-2. PubMed ID: 9712619
    [No Abstract]   [Full Text] [Related]  

  • 53. Effectiveness and Safety of Hydroxyurea in the Treatment of Sickle Cell Anaemia Children in Jos, North Central Nigeria.
    Ofakunrin AOD; Oguche S; Adekola K; Okpe ES; Afolaranmi TO; Diaku-Akinwumi IN; Zoakah AI; Sagay AS
    J Trop Pediatr; 2020 Jun; 66(3):290-298. PubMed ID: 31608959
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hydroxyurea Improves Oxygen Saturation in Children With Sickle Cell Disease.
    Pashankar FD; Manwani D; Lee MT; Green NS
    J Pediatr Hematol Oncol; 2015 Apr; 37(3):242-3. PubMed ID: 25222060
    [No Abstract]   [Full Text] [Related]  

  • 55. Hydroxyurea, sickle cell disease and renal transplantation.
    Allen A; Scoble J; Snowden S; Hambley H; Bellingham A
    Nephron; 1997; 75(1):106-7. PubMed ID: 9031282
    [No Abstract]   [Full Text] [Related]  

  • 56. Two assays to evaluate potential genotoxic effects of hydroxyurea in sickle cell disease patients.
    Rodríguez A; Kouegnigan L; Ferster A; Cotton F; Duez P
    Hemoglobin; 2012; 36(6):545-54. PubMed ID: 23094637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hydroxyurea therapy in sickle cell anemia patients in Curaçao, The Netherlands Antilles.
    Saleh AW; Velvis HJ; Gu LH; Hillen HF; Huisman TH
    Acta Haematol; 1997; 98(3):125-9. PubMed ID: 9352741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute leukemia in a patient with sickle-cell anemia treated with hydroxyurea.
    Wilson S
    Ann Intern Med; 2000 Dec; 133(11):925-6. PubMed ID: 11103075
    [No Abstract]   [Full Text] [Related]  

  • 59. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
    Anderson N
    Pediatr Nurs; 2006; 32(6):541-3. PubMed ID: 17256291
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intensive hydroxyurea dosing in very young children with sickle cell anemia.
    Wang WC; Brown RC; McNaull MA; Rogers ZR; Barton M; Dua MR; Hankins JS; Gossett J; Richardson J; Porter JS; Kang G; Estepp JH
    Blood Adv; 2023 Nov; 7(22):6931-6935. PubMed ID: 37695741
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.